Evolus Q3 revenue $69M (+13% YoY); expects Q4 non-GAAP operating profit $5-7M

Evolus, Inc.

2025-Q3 EPS reported -$0.80 revenue$206,876,000

Q3 total net revenue $69.0M, up 13% YoY; global Jeuveau $63.2M, Evolysse $5.7M.
GAAP operating loss $11.5M; non-GAAP operating loss $3.1M, improved from $6.7M in Q3 2024.
Now expects positive non-GAAP operating income of $5M-$7M in Q4 2025 and sustainable annual profitability from 2026.
Reaffirms FY2025 revenue guidance $295M-$305M and non-GAAP OpEx $208M-$213M.
Evolysse launch with $5.7M revenue described as strongest HA filler debut in over a decade.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.